Black Diamond Therapeutics, Inc.
BDTX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001701541
No open-market purchases or sales by Black Diamond Therapeutics, Inc. insiders were filed in the last 90 days; 96 institutions reported holding it in 13F filings for Q2 2026, worth $64.9M in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Black Diamond Therapeutics, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 59
- −10 vs. Q3 2022
- Shares held
- 21.1M
- −441.1K (−2.1%) vs. Q3 2022
- Total value
- $37.9M
- +$1.54M (+4.2%) vs. Q3 2022
- New holders
- 9
- 8 more added
- Sold out
- 19
- 26 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BDTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 96 | $64.9M |
| Q1 2026 | 104 | $82.0M |
| Q4 2025 | 104 | $92.0M |
| Q3 2025 | 91 | $147.0M |
| Q2 2025 | 94 | $95.8M |
| Q1 2025 | 85 | $63.0M |
| Q4 2024 | 88 | $102.5M |
| Q3 2024 | 96 | $211.9M |
| Q2 2024 | 90 | $217.9M |
| Q1 2024 | 88 | $199.9M |
| Q4 2023 | 76 | $107.1M |
| Q3 2023 | 73 | $106.8M |
| Q2 2023 | 74 | $209.2M |
| Q1 2023 | 50 | $40.6M |
| Q4 2022 | 59 | $37.9M |
| Q3 2022 | 69 | $36.3M |
| Q2 2022 | 74 | $52.9M |
| Q1 2022 | 87 | $63.5M |
| Q4 2021 | 95 | $123.7M |
| Q3 2021 | 101 | $206.3M |
| Q2 2021 | 102 | $309.6M |
| Q1 2021 | 113 | $705.5M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Black Diamond Therapeutics, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bellevue Group AG | 5,400,839 | $9.72M | 0.13% | +683,726+14.5% | Added |
| NEA Management Company, LLC | 3,448,757 | $6.21M | 0.35% | −1,0880.0% | Reduced |
| Ra Capital Management, L.P. | 2,589,904 | $4.66M | 0.09% | 00.0% | Unchanged |
| Boxer Capital, LLC | 2,014,858 | $3.63M | 0.20% | 00.0% | Unchanged |
| Artal Group S.A. | 1,646,517 | $2.96M | 0.17% | 00.0% | Unchanged |
| BlackRock Inc. | 993,769 | $1.79M | 0.00% | −269,748−21.3% | Reduced |
| Citadel Advisors LLC | 773,798 | $1.39M | 0.00% | +733,149+1,803.6% | Added |
| Vanguard Group Inc | 757,585 | $1.36M | 0.00% | +487+0.1% | Added |
| Millennium Management LLC | 524,557 | $944.0K | 0.00% | +177,577+51.2% | Added |
| Newtyn Management, LLC | 315,000 | $567.0K | 0.12% | −35,000−10.0% | Reduced |
| EcoR1 Capital, LLC | 282,131 | $507.8K | 0.02% | +282,131 | New |
| Geode Capital Management, LLC | 265,290 | $477.0K | 0.00% | +743+0.3% | Added |
| Renaissance Technologies LLC | 220,613 | $397.0K | 0.00% | +2,913+1.3% | Added |
| Two Sigma Advisers, LP | 212,500 | $382.5K | 0.00% | −2,100−1.0% | Reduced |
| K2 Principal Fund, L.P. | 158,192 | $284.7K | 0.08% | −873,319−84.7% | Reduced |
| Federated Hermes, Inc. | 155,219 | $279.4K | 0.00% | −4,329−2.7% | Reduced |
| MPM Oncology Impact Management LP | 144,888 | $260.8K | 0.07% | −95,000−39.6% | Reduced |
| Two Sigma Investments, LP | 143,664 | $258.6K | 0.00% | −64,229−30.9% | Reduced |
| Tekla Capital Management LLC | 131,990 | $237.6K | 0.01% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 125,000 | $225.0K | 0.01% | 00.0% | Unchanged |
| DAFNA Capital Management LLC | 97,500 | $175.5K | 0.05% | −216,100−68.9% | Reduced |
| State Street Corp | 76,384 | $137.5K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 65,814 | $118.5K | 0.00% | −23,782−26.5% | Reduced |
| Dimensional Fund Advisors LP | 52,522 | $95.0K | 0.00% | −7,524−12.5% | Reduced |
| Acadian Asset Management LLC | 53,365 | $95.0K | 0.00% | +53,365 | New |
| State of Wisconsin Investment Board | 41,200 | $74.2K | 0.00% | −23,300−36.1% | Reduced |
| Northern Trust Corp | 37,983 | $68.4K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 37,006 | $66.6K | 0.00% | −17,972−32.7% | Reduced |
| AE Wealth Management LLC | 35,947 | $64.7K | 0.00% | −100.0% | Reduced |
| Beacon Capital Management, LLC | 35,615 | $64.1K | 0.02% | 00.0% | Unchanged |
| Marquette Asset Management, LLC | 34,400 | $61.9K | 0.02% | +34,400 | New |
| Morgan Stanley | 31,202 | $56.2K | 0.00% | −197,987−86.4% | Reduced |
| HSBC Holdings PLC | 24,156 | $43.2K | 0.00% | +110.0% | Added |
| Ergoteles LLC | 20,212 | $36.4K | 0.00% | −30,135−59.9% | Reduced |
| Barclays PLC | 19,351 | $34.8K | 0.00% | −1,584−7.6% | Reduced |
| Bank of New York Mellon Corp | 18,191 | $32.7K | 0.00% | −74−0.4% | Reduced |
| Belvedere Trading LLC | 17,295 | $31.1K | 0.02% | +17,295 | New |
| Jane Street Group, LLC | 12,914 | $23.2K | 0.00% | +12,914 | New |
| Bank of America Corp | 12,814 | $23.1K | 0.00% | −2,272−15.1% | Reduced |
| Cambridge Investment Research Advisors, Inc. | 11,231 | $20.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 3,433 | $6.18K | 0.00% | −1,942−36.1% | Reduced |
| Tower Research Capital LLC (TRC) | 3,465 | $6.00K | 0.00% | −810−18.9% | Reduced |
| Advisor Group Holdings, Inc. | 2,782 | $5.00K | 0.00% | +522+23.1% | Added |
| Belpointe Asset Management LLC | 1,201 | $2.16K | 0.00% | +1,201 | New |
| US Bancorp | 700 | $1.26K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 552 | $1.00K | 0.00% | −1,474−72.8% | Reduced |
| Federation des caisses Desjardins du Quebec | 280 | $504 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 239 | $430 | 0.00% | −496−67.5% | Reduced |
| Citigroup Inc | 135 | $243 | 0.00% | −438−76.4% | Reduced |
| CoreCap Advisors, LLC | 120 | $216 | 0.00% | +120 | New |
| GWM Advisors LLC | 113 | $173 | 0.00% | +113 | New |
| New England Capital Financial Advisors LLC | 24 | $72 | 0.00% | +24 | New |
| Beaird Harris Wealth Management, LLC | 36 | $65 | 0.00% | 00.0% | Unchanged |
| Salem Investment Counselors Inc | 35 | $63 | 0.00% | 00.0% | Unchanged |
| Investors Research Corp | 30 | $54 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 9 | $16 | 0.00% | −281−96.9% | Reduced |
| Royal Bank of Canada | 195 | $0 | 0.00% | −176−47.4% | Reduced |
| CWM, LLC | 9 | $0 | 0.00% | 00.0% | Unchanged |
| TSFG, LLC | 100 | $0 | 0.00% | 00.0% | Unchanged |
| Deutsche Bank AG | 0 | $0 | 0.00% | −321,602−100.0% | Sold out |
| Connor, Clark & Lunn Investment Management Ltd. | 0 | $0 | 0.00% | −82,881−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −22,486−100.0% | Sold out |
| Bailard, Inc. | 0 | $0 | 0.00% | −21,281−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −18,813−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −18,764−100.0% | Sold out |
| Redmond Asset Management, LLC | 0 | $0 | 0.00% | −15,978−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −15,973−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −14,000−100.0% | Sold out |
| Mariner, LLC | 0 | $0 | 0.00% | −10,734−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −10,541−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −10,703−100.0% | Sold out |
| Leonteq Securities AG | 0 | $0 | 0.00% | −5,000−100.0% | Sold out |
| Capital Advisors, Ltd. LLC | 0 | $0 | 0.00% | −476−100.0% | Sold out |
| Global Trust Asset Management, LLC | 0 | $0 | 0.00% | −634−100.0% | Sold out |
| China Universal Asset Management Co., Ltd. | 0 | $0 | 0.00% | −341−100.0% | Sold out |
| First Manhattan Co | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| Clearstead Advisors, LLC | 0 | $0 | 0.00% | −82−100.0% | Sold out |
| Daiwa Securities Group Inc. | 0 | $0 | 0.00% | −106−100.0% | Sold out |